NCT04260529 - CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

July 5, 2024

Study Completion Date

July 5, 2024

Conditions

Advanced Solid Tumor Malignancy

Interventions

DRUG

CyPep-1

Intratumoral injection

DRUG

Pembrolizumab 25 MG/ML [KEYTRUDA®]

IV infusion

Trial Locations (8)

Institue Curie, Paris

Institute Gustave Roussy, Villejuif

NKI/AvL, Amsterdam

LUMC, Leiden

EMC, Rotterdam

UMCU, Utrecht

Vall d'Hebron (VHIO), Barcelona

START, Madrid